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on Target Ion ChannelsJenny Tigerholm†‡ and Erik Franse´n†‡*
†Department of Computational Biology, School of Computer Science and Communication and ‡Stockholm Brain Institute, Royal Institute of
Technology, Stockholm, SwedenABSTRACT In diseases of the brain, the distribution and properties of ion channels display deviations from healthy control
subjects. We studied three cases of ion channel alteration related to epileptogenesis. The first case of ion channel alteration
represents an enhanced sodium current, the second case addresses the downregulation of the transient potassium current
KA, and the third case relates to kinetic properties of KA in a patient with temporal lobe epilepsy. Using computational modeling
and optimization, we aimed at reversing the pathological characteristics and restoring normal neural function by altering ion
channel properties. We identified two key aspects of neural dysfunction in epileptogenesis: an enhanced response to synaptic
input in general and to highly synchronized synaptic input in particular. In previous studies, we showed that the potassium
channel KA played a major role in neural responses to highly synchronized input. It was therefore selected as the target
upon which modulators would act. In biophysical simulations, five experimentally characterized endogenous modulations on
the KA channel were included. Relative concentrations of these modulators were controlled by a numerical optimizer that
compared model output to predefined neural output, which represented a normal physiological response. Several solutions
that restored the neuron function were found. In particular, distinct subtype compositions of the auxiliary proteins Kv channel-
interacting proteins 1 and dipeptidyl aminopeptidase-like protein 6 were able to restore changes imposed by the enhanced
sodium conductance or suppressed KA conductance. Moreover, particular combinations of protein kinese C, calmodulin-
dependent protein kinase II, and arachidonic acid were also able to restore these changes as well as the channel pathology
found in a patient with temporal lobe epilepsy. The solutions were further analyzed for sensitivity and robustness. We suggest
that the optimization procedure can be used not only for neurons, but also for other organs with excitable cells, such as the heart
and pancreas where channelopathies are found.INTRODUCTIONEpilepsy is a severe neurological disorder with a prevalence
rate of 5–10 per 1000 individuals (1,2). There are many
different forms of epilepsy, all characterized by spontaneous
recurrent seizures. A seizure has a rich repertoire of events
and one pronounced feature is highly synchronized neural
activity (3). Synchronous input is very powerful in acti-
vating neurons (4) and therefore an enhanced neural
response can therefore be part of the pathology. The under-
lying mechanisms generating the pathology are numerous.
Sodium channels have been the major focus of epilepsy
research involving ion channels (5). Both gene mutation
studies and animal models have shown sodium current
involvement in epileptogenesis (5,6). Other channels, such
as the A-type potassium channel (KA), have also been linked
to epilepsy (7–10). In animal models, the KA current and
gene expression is downregulated (8,9). Furthermore, in
a human genetic study a mutation in the KA gene was linked
to temporal lobe epilepsy (TLE) (7). When the mutated gene
was expressed in human embryonic kidney cells, the KASubmitted April 15, 2011, and accepted for publication August 24, 2011.
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0006-3495/11/10/1871/9 $2.00current was strongly reduced. Moreover, in a study on
human epileptic tissue from a patient with TLE (10), it
was shown that the KA current had altered dynamics com-
pared to the native current.
In epileptogenesis, a multitude of activity changes have
been discussed, one of which is enhanced synchronicity at
or before the onset of a seizure. Synchronous activity can
generate compound excitatory postsynaptic potentials
(EPSPs) with a fast rise time and high amplitude. Such input
has been shown in vivo and in vitro to be particularly effi-
cient in activating the neuron (11). Epileptic seizures are
also characterized by excess spiking. Therefore, we have
chosen to study neural excitability from the point of view
of the generation of action potentials in response to synaptic
input produced by network activity. To address excitability
at the single neuron level, we focused on controlling the
cellular spiking responses to different levels of synchro-
nized input. In previous work (12), we studied the spiking
of a neuron in response to the input of different degrees of
synchronicity. We identified a particular potassium channel,
KA that was able to selectively reduce the neuronal
responses to the most synchronized input. In the study pre-
sented here, we defined two goals: to reduce responses to
highly synchronized input, representing activity during epi-
leptogenesis, and to obtain a normal response to input of
lower synchronicity levels corresponding to normal levelsdoi: 10.1016/j.bpj.2011.08.055
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FIGURE 1 Neuron spiking response to different synchronicity levels.
The three columns represent simulations with the following synchronicity
levels; full (0 ms; left), medium (6 ms; middle), and low (12 ms; right)
synchronicity of the inputs. Input was placed at three locations with the
distance from the soma: 239, 295, and 339 mm. At each input location 20
synapses were placed. Arrival time for the temporal midpoint of the input
is 300 ms. The same input was used for all figures if not stated otherwise.
(A) Temporal distribution of the input. (B) Membrane potential at the input
site for one input cycle. (C) The membrane potential in the soma for the full
1500 ms simulation. (D) Number of spikes produced for different levels of
synchronized input, from fully synchronized (0 ms) to desynchronized
(15 ms). We show the spike activity when KA is present in the model
(blue) and when the conductance of KA is reduced with 40% (black dotted
line). Note the strong reduction of spike activity in the 0–1 ms interval when
KA is present. Closed boxes correspond to synchronicity levels and spike
counts shown in C. (E) The spatial distribution of the input. Each arrow
corresponds to 20 synaptic contacts with the temporal distribution
shown in A.
1872 Tigerholm and Franse´nof excitability. These functional criteria were used as con-
straints for a numerical optimizer cost function. The pattern
search method was chosen because it is a robust direct
search method (13–15). We further analyzed the solutions
we found in terms of parameter sensitivity and robustness.
In this study, we identified three cases of ion channel
alterations associated with epileptogenesis. The first case
showed enhanced sodium currents (16) and was represented
in the model by increasing the transient sodium conduc-
tance. The second case of epilepsy addressed a downregula-
tion of the KA current (7) represented by reducing the KA
conductance. The third case is related to properties of KA
in a patient with temporal lobe epilepsy and was imple-
mented using the measured biophysical properties. In a
previous study, we showed that KA may be beneficial in
reducing epileptogenic activity (12). In this study, we
focused on improving the functional behavior of the neuron
and aimed at reversing the pathological change in neural
response characteristics. We studied the modulation of KA
by intracellular messengers. There are many modulatory
substances that modulate the KA channel, such as auxiliary
proteins, kinases, and polyunsaturated fatty acids (17–21).
The main focus of this study was on subtypes of the
two auxiliary proteins Kv channel-interacting proteins 1
(KChIP1) and dipeptidyl aminopeptidase-like protein 6
(DPP6) because of their selectivity toKA.However, the study
also included the modulatory substances protein kinase
C (PKC), calmodulin-dependent protein kinase II (CaMKII),
and arachidonic acid (AA). By using experimentally derived
modulations of ion channel properties in the simulations,
the solutions from the optimizer were the relative concentra-
tions of the modulatory substances. These can be experimen-
tally tested. If the compounds or their binding sites on KA
have suitable properties, theymay be of interest for a pharma-
cological intervention.MATERIALS AND METHODS
Cell model
All simulations were performed using the simulator NEURON (22). As
a model of the physiological control condition, we used the CA1 pyramidal
neuron model by Poolos et al. (23). The ion channels were described by
Hodgkin-Huxley dynamics (see Supporting Material for the ionic equa-
tions). The model with no changes is referred to as the control model and
models with changes are referred to as pathological models in the study.
During the simulation, 15 cycles of input were delivered for 1500 ms;
each cycle consisted of one input each at 60 synapses activated at a partic-
ular degree of synchronicity. Fig. 1 A shows three examples of input
synchrony, ranging from fully synchronized (all synapses activated at the
same time) to relatively asynchronous input. Synchronicity is measured
as the temporal standard deviation of the synaptic input and is generated
from a normal distribution. As expected, the general trend was that more
synchronized activity lead to the production of more spikes. However,
note the reduced spike activity for synchronicity levels 0 and 1 ms (see
Fig. 1 C), which corresponds to highly synchronized synaptic input. In
our previous study, we showed that this low response is due to selective acti-
vation of KA.Biophysical Journal 101(8) 1871–1879Models of epilepsy
A range of ion channels have been linked to epileptogenesis, particularly
sodiumandpotassiumchannels.The involvement of theKAchannel in epilep-
togenesis has been studied in both animal models and in human tissue (7–9).
Some of these studies show a downregulation of the gene expression or the
current of KA (24). The model describing this case was labeled reduced KA
model andwas implemented as a reduction of the conductance ofKA by 50%.
The sodium channel has been strongly implicated in epileptogenesis,
particularly since several gene mutations have been linked to epilepsy
(6). A study on kindling epileptogenesis recorded a 22% increase in peak
sodium current (16) and a 3 mV depolarizing shift of the steady-state inac-
tivation curve. This model is referred to as the increased sodium model.
In human tissue from a patient with temporal lobe epilepsy (10), alter-
ations in the dynamics of KA have been described. The steady-state param-
eters from the study were implemented in a model labeled TLE model. The
activation time constant was similar to data of native KA and we therefore
used the value of the control model. For more details of the models of the
pathological models see Supporting Material.
The activity of the pathological cell models was measured for different
levels of synchronized input, shown in Fig. 2. The pathological models
had enhanced responses to highly synchronized input (synchronicity ¼
0–1 ms) and general excitability (synchronicity ¼ 11–19 ms) was also
increased for the models.
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FIGURE 2 Increased excitability induced by pathological channel
changes. The number of spikes produced for different levels of synchro-
nicity is shown. Spiking in the control case is shown in blue and patholog-
ical cases are shown in red. The top trace shows the spike activity produced
by the reduced KA model, the middle shows the increased Na model, and
the bottom trace the TLE model. Note the increased activity for all three
pathological models to highly synchronized input (<2 ms) and to lower
levels of synchronized input (>10 ms).
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A short description of the implementation of the modulatory substance
follows.
KChIP1
An upregulation of KChIP1 was modeled as an increase of the conductance
of KA and decrease of the inactivation time constant. If KChIP1 was down-
regulated the conductance was reduced and the inactivation time constant
increased (see Supporting Material for the equation).
DPP6
DPP6 alters the V1/2 of both the activation and inactivation steady-state
functions as well as the inactivation time constant (18). This was imple-
mented as a shift of the steady-state activation curve from a hyperpolarizing
shift of 13.5 mV (highest relative concentration of DPP6) to a depolarizing
shift of 13 mV (lowest relative concentration of DPP6). For the steady-state
inactivation curve a shift from a hyperpolarizing shift of 7.5 mV to a depo-
larizing shift of 7.5 mV was used (corresponding to high and low relative
concentration of DPP6). See Supporting Material for the description of
the modulation of the inactivation time constant.
PKC
PKC activators downregulate the KA current by shifting the steady-state
activation curve (19). In the model, we implemented PKC modulation of
KA as a shift of the steady-state curve from a depolarizing shift of 15 mV
to a hyperpolarizing shift of 15 mV (corresponding to high and low relative
concentration of PKC).
AA
The polyunsaturated fatty acid AA shifts the steady-state inactivation curve
12 mV to more negative potentials (25). In the model, we implemented the
modulation of AA as a shift of the steady-state inactivation curve from a
hyperpolarizing shift of 12 mV to a depolarizing shift of 12 mV (corre-
sponding to high and low relative concentration of AA).CaMKII
Ca2þ/calmodulin-dependent protein kinase II (CaMKII) upregulates the
channel expression of KA without affecting the biophysical properties of
KA (20). CaMKII modulation of KA was implemented as an up to twofold
increase of the conductance of KA. A decreasing level of CaMKII was im-
plemented as a reduction of the conductance of KA by a factor of up to two.
Functionally correcting the models of epilepsy
by KChIP1 and DPP6
To reverse pathological changes, a numerical optimizer was used to search
for improved models. We chose the pattern search method by Hook and
Jeeves (15). It is a direct search algorithm, has a fast convergence, and
handles a discontinuous cost function (13,14).
We defined the cost function so that the main goal of the optimizer was to
functionally correct the pathological models. In this case, functionally cor-
rected means a changed pathological model where a spiking output resem-
bled the output of the control model (see Fig. 3 for a description of the
optimization method). Basing a cost function on the number of generated
spikes gives a discrete output that is produced by a threshold type of
process. The use of a cost function described by small integers gives rise
to slow optimizer convergence. We therefore used the membrane potential,
which is a good predictor of spike activity, because spikes are produced by
a process that is dependent on membrane potential. For a description of the
cost function see Supporting Material. The optimizer found only one
minimum when the relative proportions of subtypes of KChIPs or DPPs
were the free variable. Fig. 3, B–E, shows the steps the optimizer chose
to functionally correct the increased Na model.
RESULTS
For the reduced KA model and increased sodium model,
an increased concentration of KChIP1 could functionally
correct spike activity (Fig. 4 and Table 1). Both these func-
tionally corrected models could reduce highly synchronized
input and normalize general excitability. Furthermore, by
increasing the relative concentration ofDPP6, a similar result
could be attained (Fig. 4 and Table 1). In the increased
sodium model, we noted that DPP6 reduced general excit-
ability to levels below that of the control model. However,
the TLE model could not be functionally corrected
by changing either the relative concentration of KChIP1 or
DPP6. This was due to limitations of the range of modulation
by DPP6 and KChIP1. If instead a pure shift of the steady-
state curves of KA was used as a hypothetical modulator,
the optimizer could find a solution (data not shown). This
showed that the failure of the KChIP1 and DPP6 cases was
not due to a shortcoming of the optimization process.
Fig. 5 shows the membrane potential during a simulation
of the control model, the increased Na model, and its func-
tionally correctedmodel byDPP6. In the pathologicalmodel,
the cell was hyperexcitable for high synchronicity levels. In
the functionally corrected model, the spike activity was
very similar to the control case. Spike activity was reduced
for the high synchronicity (<2 ms) and low synchronicity
levels (>10 ms). The desynchronized input (2–5 ms) gener-
ated a high spike activity, as intended. However, the 6–10 ms
interval generated spikes in the control model but not in the
functionally corrected model.Biophysical Journal 101(8) 1871–1879
AB C
D E
FIGURE 3 Optimization method. (A) The
method we used to find functionally corrected
models, starting with pathological models. The
compound EPSP from the pathological model
was compared to the control model to generate
the cost value. If the cost value was high, new rela-
tive concentrations of the modulatory substances
were calculated by the pattern search method.
The new concentrations were then implemented
in the model, a new simulation was run, and
a new set of EPSPs were generated. A new cost
value was computed and when this fell below the
stop criteria the model was labeled functionally
corrected. (B) The spiking response for different
synchronicity levels during the optimization proce-
dure. The starting point of the optimization is the
pathological model (red) and the goal is the control
model (blue). For illustration, spike activity for
each iteration during the optimization is also
shown (dashed lines). Final solution found is indi-
cated in green. Each color in B, D, and E corre-
sponds to the same iteration cycle. (C–E)
Illustrates the optimization cycle. (C) Dendrite
membrane potential produced in a control case
(blue) and a pathological case (red). The difference
in peak EPSP amplitude at the input site for the first
and second input cycles were used to calculate the
cost function value. (D) The cost function value for
each iteration during the optimization. (E) The
relative concentration of DPP6 for each iteration
of the optimization.
1874 Tigerholm and Franse´nTo study the ability of KA to reduce synchronized input we
measured themembrane potential at different locations along
the dendrite when a depolarization was propagating to the
soma (see Fig. 5D). In Fig. 5Dwe show themembrane poten-
tial for the functionally corrected model (DPP6) and the
increased sodium model. At the synaptic input site (240 mm
from the soma) the two models have a similar depolarization
for high levels of synchronized input, however during the
propagation to the soma the two models diverge. The patho-
logicalmodel generates a spike but the functionally corrected
model does not. Fig. 5D shows that the ability ofKA to reduce
synchronized input is a filtering process along the dendrite.Sensitivity analysis on the functionally corrected
model modulated by DPP6
Avariance-based sensitivity analysis (26) was used to inves-
tigate how the different modulatory effects of DPP6 in-
fluenced spike activity. Fig. 6 A shows the first-order
sensitivity index for the functionally corrected increased Na
model. The sensitivity index measures the influence ofBiophysical Journal 101(8) 1871–1879a specific parameter on one feature of the model, in this
case the spike activity (see Supporting Material for further
information). The parameters used for this analysis were the
different effects of DPP6 onKA; shifting the steady-state acti-
vation curve, shifting the inactivation steady-state curve, and
a change in the inactivation time constant. We note that the
largest impact comes from the steady-state activation curve
shift (Fig. 6 A). Fig. 6 A shows the sensitivity index when
the intervals of change were set to510%. The spike activity
for desynchronized input (1–4 ms) was not affected by the
changes. For high synchronicity levels (0–1ms) thefirst-order
sensitivity index is large. However, if we plot the variance
(i.e., the without normalizing by the mean), we see that the
actual number of spikes is quite small (see Fig. 6B). Together,
this indicates that the solution found is robust in reducing
highly synchronized input. The variance-based sensitivity
analysis indicated that the DPP6 modulation on KA might
be simplified. In Fig. 6 C, the three different modulations of
KAwere removed one at a time from the model and we tested
whether the model was still functionally corrected. Only the
modulation of the steady-state inactivation time constant
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FIGURE 4 DPP6 and KChIP1 can functionally correct two of the patho-
logical models. The figure shows spike activity during control conditions
(blue) and spike activity for the pathological models (red). The top trace
shows the spike activity produced by the reduced KA model, the middle
increased Na model, and the bottom the TLE model. We show the function-
ally corrected pathological models (dotted lines) when KChIP1 was used as
a free variable (black) and when DPP6 was used as the free variable (green).
Reversing Neuron Pathology by Optimizing 1875could be removed without major effects on the degree to
which the model is functionally corrected. The three modula-
tions ofDPP6 affect the excitability of the cell differently. The
steady-state activation and inactivation time constantmodula-
tion both reduce the excitability of the model. The steady-
state inactivation modulation, on the contrary increases theTABLE 1 Parameter values for solutions found by the optimizer
Relative concentration
of the substance
Shift of the st
activation cu
KChIP1 red. KA 2.00 –
inc. Na 1.63
DPP6 red. KA 1.80 9.2
inc. Na 1.69 10.
PKC red. KA 0.21 11.
inc. Na 0.34 9.9
CaMKII red. KA 1.80 –
inc. Na 1.72
AA red. KA 0.00 –
inc. Na 0.00
Solution A
PKC, CaMKII, AA red. KA 0.52 1.66 1.53 7.1
inc. Na 1.13 1.67 0.44 1.94
TLE 0.00 2.00 0.00 15.
Solution B
PKC, CaMKII, AA red. KA 0.73 1.73 1.30 4.1
inc. Na 0.79 1.27 0.62 3.0
Solution C
PKC, CaMKII, AA red. KA 0.40 1.77 1.73 9.0
inc. Na 0.72 1.47 1.21 4.1
Solutions found by the optimizer for the pathologies. In the table the alteration
shown. Negative shifts correspond to a hyperpolarizing shift of a steady-state
The inactivation time constant alterations are described in the Supporting Mateexcitability. Simplifying the model of how modulation of
DPP6 changes the properties of KA is therefore not trivial.Functionally correcting the models of epilepsy
by PKC, AA, and CaMKII
The properties of ion channels are subject to dynamic modu-
latorybalance (27).KA changes dependingon its kinetic prop-
erties following, e.g., phosphorylation.We therefore extended
our analysis to include modulatory alterations of PKC (19)
and CaMKII (20) as well as the lipid messenger AA (25).
First, the effects of the modulatory substances were studied
one by one and second, because PKC, AA, and CaMKII do
not have a strong mutual interaction regarding their effects
on KA, their combined affect was studied.
When PKC, CaMKII, and AA were studied in isolation
both the reduced KA model and increased Na model could
be functionally corrected but not the TLE model (see
Fig. 7). However, three free parameters PKC, AA, and
CaMKII together, could functionally correct all three path-
ological models (see Fig. 7). For the reduced KA and
increased Na model, multiple minima could be found. The
solutions are presented in the Table 1.Sensitivity and robustness analysis on the
functionally corrected model by PKC, AA, and
CaMKII
Results from the increased Na model were further analyzed.
The three solutions with the lowest cost function score areeady-state
rve (mV)
Shift of the steady-state
inactivation curve (mV) Conductance change (%)
– 1.71
1.45
8 5.16 –
8 6.00
9 - –
0
- 1.80
1.72
12.0 –
12.0
8 6.36 1.66
6.72 1.67
0 12.0 2.00
3 3.60 1.73
8 4.44 1.27
8 8.70 1.77
7 2.50 1.47
of the steady-state curves and conductance for the different solutions are
curve and positive shift to a depolarizing shift of the steady-state curve.
rial.
Biophysical Journal 101(8) 1871–1879
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FIGURE 5 Membrane potentials for the func-
tionally corrected increased Na model by DPP6.
The three columns in A and B represent simulations
with synchronicity levels of 0 ms (left), 5 ms
(middle), and 10 ms (right). The first input cycle
was set to have a midpoint at 300 ms. (A) The
membrane potential at the input site in the control
model. (B) The membrane potential in the soma in
the control model (blue), pathological model (red),
and functionally corrected model (green). (C) The
spike activity for different levels of synchronized
input. The control model (blue), the increased Na
model (red), and the functionally corrected model
(green) are shown. Boxes indicate synchronicity
levels used in the three columns in the traces above.
(D) The membrane potential from the increased Na
model (red) and functionally corrected model cor-
rected by DPP6 (green) are shown. The left column
shows the simulation with 0 ms and the right
column with 10 ms synchronicity. The different
rows (top to bottom) show the membrane potential
at decreasing distances from the soma. Note for the
left column how the EPSP amplitude is decreased
when it propagates to the soma.
1876 Tigerholm and Franse´nshown in Fig. 8. Because there were multiple functionally
corrected model solutions for each pathological model,
this gave rise to the question of which solution was the
preferred one. Not only was it important for the model to
be functionally corrected, but we also wanted an adequate
level of parameter sensitivity (not too sensitive for parame-
ters relevant to the problem, but at the same time not totally
indifferent). Furthermore, the robustness of the solution is
also highly important. If small alterations to the model
lead to an output that is characteristic of a pathological
model, the model will in the following be termed not robust.0 2 4 6 8 10 12 14
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Biophysical Journal 101(8) 1871–1879Robustness can thus be viewed as the parameter interval
within which the model produces output that is classified
as functionally corrected.
As a first step into examining the quality of the solutions,
we measured the spike variance when the input variables
(PKC, AA, and CaMKII) were varied within 519% of the
allowed parameter interval. The three models had similar
spike activity dependencies (see Fig. 8). Notice that the vari-
ance for synchronicity levels between 2 and 4 ms is low. This
meant that the solutions were not sensitive in the region
where a maximum firing of the neuron was expected.16 18
7 8
7 8
FIGURE 6 Sensitivity analysis. (A) Variance-
based sensitivity analysis of the corrected increased
Na model corrected by DPP6. Interval of variation
was510% of the parameter interval. (B) Variance
of spike activity (nonnormalized sensitivity index)
when the effects from DPP6 on the KA channel
were varied one at a time. (C) Spike activity is
shown when one modulation property at a time
(out of the three included) was omitted in the func-
tionally corrected model of reduced Na pathology
corrected by DPP6. Spike activity in the patholog-
ical model with increased Na (red), and the control
model (blue) are shown. The dotted curves rep-
resent cases where one modulation was omitted,
showing inactivation time constant (green), steady-
state activation (black), and steady-state inactivation
(purple).
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FIGURE 7 PKC, AA, and CaMKII can functionally correct all patholog-
ical models. The figure shows the spike activity for the functionally cor-
rected models (dotted lines), pathological models (red), and the control
model (blue). The top trace represents the reduced KA model, middle the
increased Na model, and bottom the TLE model. The left column shows
solution when the PKC (purple), CaMKII (orange), and AA (black) effect
is studied in isolation and the right the combinations of them. If there exist
multiple solutions, the three best functionally corrected models (A in light
blue, B in pink, and C in green) are shown.
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FIGURE 8 Sensitivity analysis. Results from the increased Na model,
solution A (blue), B (pink), C (green). (A) Data points visited by the opti-
mizer with a cost function value below two are shown. Axes values are
in arbitrary concentration units. (B) Variance of spike activity in the func-
tionally corrected increased Na model when PKC (purple), CaMKII
(orange), and AA (black) were changed by 519% of the parameter
interval. The left column represents solution A, the middle column solution
B, and right column solution C.
Reversing Neuron Pathology by Optimizing 1877However, in such important regions as the high synchronicity
region of 0–2ms and the low synchronicity region of 4–9ms,
they were sensitive and thus contributed to the model
behavior. Fig. 8B also shows that PKC is the most influenced
modulatory substance on the spiking output compared.
Second, the solutions were examined in terms of their
robustness. Tomeasure the robustness of a solution, a param-
eter value of the solution was increased or decreased until
the model was not classified as functionally corrected (see
Supporting Material for more information). The sum of
the two intervals (the increased and decreased) was defined
as the width of the parameter (see Table 2). Solution B (pink
in Fig. 7) had the lowest cost function value but smaller
width than solution A and C (light blue and green in
Fig. 7). When the minima were examined closer, the minima
of solution A were not symmetrical. For instance, PKC
could be increased by a factor of 20% but could merely
be decreased <5%. All the parameters, which in this way
could only be decreased or increased by <10%, are high-
lighted in bold in Table 2. The robustness score was
decreased by one upon each such occurrence. Solution C
had the highest robustness score and the two other solutions
B and A had considerably lower robustness scores.
To extend the robustness analysis of the solutions, the
relative concentration found by the optimizer were imple-
mented in the model by Poirazi et al. (28). We choose the
Poirazi model because it is one of the most well-studiedmodels of dendritic integration. A similar result could be
obtained in the Poirazi model, 7 of 10 solutions were func-
tionally corrected. See Supporting Material for more
information.DISCUSSION
We studied how a combination of parameter search optimi-
zation and simulation of a biophysical neuron model could
be used to reverse pathological cellular signatures and
thereby restore normal neuronal function. We applied the
procedure to three cases of ion channel disturbances linked
to epileptogenesis. Modulations of the potassium channel
KA, as reported for the auxiliary proteins KChIPs and
DPPs, could restore two of the cases; a decreased conduc-
tance of KA and an increased conductance of a sodium
channel. Conversely, changed levels of KChIPs and DPPs
were unable to functionally restore ion channel alteration
of KA measured in a patient suffering from temporal lobe
epilepsy. However, using modulation of KA by the three
modulatory substances PKC, CaMKII, and AA, we could
functionally correct the alteration due to the pathology in
all three cases.
We chose the optimization method developed by Hook
and Jeeves (15). It is a direct search algorithm and thereby
does not rely on computing derivatives. It has a fast conver-
gence and can handle a discontinuous cost function (13,14).
We found the pattern search method to be stable and fast
enough to be useful for the optimization problem we haveBiophysical Journal 101(8) 1871–1879
TABLE 2 Characterization of three best solutions for multidimensional search
Solution Cost function value Width*
Relative concentration
of PKC (%)
Relative concentration
of CaMKII (%)
Relative concentration
of AA (%) Robustness scorey
A (blue) 1.0232 1.56 5–þ20 30–þ20 15–þ65 1
B (pink) 0.0003 1.00 0–þ20 25–D0 0–þ55 3
C (green) 0.0069 2.05 25–þ20 25–þ65 35–35 0
Characterization of three best solutions. For the three best solutions, A–C, the cost function value at the minima, the width of the minima, the endpoints of the
width, and the robustness score are shown. If a small change (<10%) can lead to epileptic behavior, the endpoint is indicated in bold and the robustness is
decreased by one. Solutions are labeled by color as in Figs. 7 and 8.
*Sum of the absolute value of columns 4, 5, and 6.
yNumber of nonrobust interval endpoints in the columns 4, 5, and 6.
1878 Tigerholm and Franse´nfocused on in this study. We have used a variance-based
sensitivity analysis (26) to investigate the sensitivity and
to estimate the influence of the different model parameters.
The analysis showed that our target channel KA exerts very
little influence for semisynchronized input, in our study
considered as normal brain activity. However, it played a
significant role in both suppression of highly synchronized
input and in controlling input of low synchronicity. This
supports the selective role of KA in suppressing synchronous
neural activity as well as controlling general excitability.
Native KA is coassembled with auxiliary proteins, KChIPs
and DPPs (18). The subunit composition affects the kinetic
properties of the channel in terms of shifts of the steady-state
activation and inactivation curves as well as changes in time
constants of activation and inactivation. These changes in
characteristics form the basis of our study because they deter-
mine what dimensions the optimizer is allowed to affect. In
our study changes due to DPP6s were implemented accord-
ing to data from DPP6 expression data (18), which are
consistent with DPP6 knockdown studies (29). Effects on
steady-state curves and time constants have also been found
for DPP10 (30) as well as for splice variants of DPP6 (31). In
the former case, shifts of the type we used in our work would
result from changes in the balance of DPP6 versus DPP10
and in the latter case between, e.g., changes in the balance
between DPP6a and DPP6L. Although every case above
would give a unique set of changes in properties, our study
shows that the robustness of the solutions found indicate
that solutions could be experimentally achieved in a number
of experimental settings.
Several animal models of epilepsy have shown a reduction
of the KA current or gene/mRNA expression (8,24). More-
over, the KChIP1 gene expression is also downregulated
by seizures (32). This rundown of KChIP1 also leads to
a reduced KA current that further increases the probability
for new seizures, potentially generating a vicious circle.
To address this problem, we implemented a model with
a reduced KA conductance. This pathological model was
hyperexcitable both for high and low synchronicity levels.
Our simulations showed that an increase of KChIP1 (rela-
tive concentration¼ 2) or of DPP6 (relative concentration¼
1.80) could functionally correct the pathological model’s
response to different levels of synchronized input.Biophysical Journal 101(8) 1871–1879In a third model of pathology, we implemented the
dynamics of KA measured in a patient with temporal lobe
epilepsy. The steady-state parameters for the pathological
KA were altered substantially with respect to the native
parameters (33–35). The steady-state inactivation function
was shifted 45 mV in the hyperpolarizing direction and
the steady-state activation function 10 mV in the same
direction. Due to the large alteration in the dynamics of
KA, neither KChIP1 nor DPP6 were able to functionally
correct this case. The limitations stem from the limits of
the modulation range in KA kinetics, which these
substances can exert on the KA channel. Several splice vari-
ants of KChIP1 and DPP6 exist and if effects from several
of these were included simultaneously in the model, the
model might become functionally corrected. This was not
tested in this study, as the interaction between these vari-
ants and how they summate is currently unknown.
However, in the case where PKC, CaMKII, and AA modu-
lations were combined, this pathology could be function-
ally corrected. PKC and CaMKII affect many essential
cellular processes and are therefore not selective to KA.
Using these to directly reduce epileptic activity would
produce several side effects. As an alternative, compounds
selective to KA that phosphorylate the same phosphoryla-
tion sites as PKC and CaMKII might be used. Furthermore,
AA and other polyunsaturated fatty acids are already used
for treatment of epilepsy (36). In several studies, children
with epilepsy were put on a high fat, low-carbohydrate
diet, leading to a reduced occurrence of seizures (36,37).
The target of the anticonvulsant effect is still unknown.
Our results support the possible beneficial role of action
on KA.
The results of this study indicate that changes in ion
channel characteristics induced by modulatory substances
may be beneficial in reducing epileptogenic activity. The
method we developed to functionally correct a pathological
neuron can be used for other brain diseases where alter-
ations of ion channels are involved. It may also be used in
other organs with excitable cells, such as the heart or
pancreas. For instance, atrial fibrillation is one of the most
common sustained cardiac arrhythmias with an underlying
pathology of cell hyperexcitability due to, among other
things, alterations of ion channels (38).
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